


GamaMabs Pharma to present new data on GM102 at two upcoming scientific conferences in November

Nosopharm appoints Dr Sarah Gould as chief development officer

Imcyse successfully completes patient enrollment in first-in-human Phase 1b study in type 1 diabetes

Bionure appoints Dr. Laurent Nguyen as CEO

Minoryx Therapeutics raises €21.3M in Series B funding round

GamaMabs Pharma starts a phase 2 study of monoclonal antibody GM102

Minoryx announces dosing of first US patient in phase 2/3 clinical study of MIN-102 (ADVANCE)

Inoviem Scientific enters into service-based partnership with XoNovo
